Expertise from Forbes Councils members, operated under license. Opinions expressed are those of the author. AI, and especially agentic AI tools, are evolving at a rapid speed, with the use of AI ...
Measurable Residual Disease and Fusion Partner Independently Predict Survival and Relapse Risk in Childhood KMT2A-Rearranged Acute Myeloid Leukemia: A Study by the International ...
TipRanks on MSN
Aptose Biosciences unveils promising AML therapy data
The latest update is out from Aptose Biosciences ( (TSE:APS) ).
Reducing Futile Acute Care Services for Terminally Ill Patients With Cancer: The Dignity Project Over the next 10 years, there will be 7,600 years of life lost and 7,337 PALYs lost because of AML, ...
Researchers assessed survival outcomes for Asian patients with newly diagnosed AML vs White patients. Researchers determined Asian patients with newly diagnosed AML may have superior OS outcomes ...
Evaxion Biotech ( ($EVAX) ) has issued an announcement. On December 6, 2025, Evaxion A/S presented new data at the ASH Annual Meeting ...
Acute myeloid leukemia (AML) can occur in both children and adults. However, the genetic drivers of disease can differ depending on the patient’s age and knowing this information may inform on ...
PureTech's Founded Entity Gallop Oncology to Present New Data from Ongoing Phase 1b Trial of LYT-200 in Relapsed/Refractory Acute Myeloid Leukemia (AML) at the American Society of Hematology (ASH) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results